Da. Moneretvautrin, THE ALLERGIC RISK OF TRANSGENIC FOODS - TRUE OR FALSE PROBLEM, Revue francaise d'allergologie et d'immunologie clinique, 38(8), 1998, pp. 693-699
Marketing of food products derived from transgenic plants corresponds
to a great variety of transgenic proteins with various functionalities
. The marked increase in the prevalence of food allergy justifies part
icular attention in relation to new allergic risks. Evaluation of the
allergenic potential of transgenic proteins, when the origin of the ge
ne is a known allergenic plant, is performed on the serum of patients
allergic to the plant providing the gene, which could be completed by
skin tests and provocation tests. When this potential is absent or unk
nown, safety parameters are the absence of sequence homology of at lea
st eight contiguous amino acids and rapid loss of immunoimpression ant
igenicity after digestion in in vitro models and after heating. An add
ition level of verification concerns the modified plant when it is kno
wn to be allergenic, in order to control the absence of modification o
f the allergenic composition. Some factors, such as the level of nutri
tional transgenic proteins, or their enzymatic nature could increase t
he risk of de novo allergenicity. As this risk cannot be predicted, po
st-marketing surveillance should be considered, which may require the
creation of an allergovigilance body.